Atlas Venture Life Science Advisors, Llc Portfolio Stock Holdings
Atlas Venture Life Science Advisors, Llc disclosed 6 stock positions valued at approximately $790.0 million in its latest SEC 13F filing. The largest holdings include Kymera Therapeutics, Inc., Dyne Therapeutics, Inc., and Sionna Therapeutics, Inc.. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 6
- Portfolio Value
- $790.0M
Holdings by Sector
Atlas Venture Life Science Advisors, Llc Portfolio Holdings in Q1 2026
6 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. | KYMR | Healthcare | 48.26% | 4,578,008 | -81,866 | -1.76% | $381,302,286 |
| Dyne Therapeutics, Inc. | DYN | Healthcare | 20.95% | 9,130,465 | - | - | $165,535,330 |
| Sionna Therapeutics, Inc. | SION | Other | 15.20% | 2,995,602 | - | - | $120,093,684 |
| Disc Medicine, Inc. | IRON | Healthcare | 12.25% | 1,513,875 | - | - | $96,797,168 |
| Q32 Bio, Inc. | QTTB | Healthcare | 1.70% | 2,092,106 | - | - | $13,431,321 |
| Korro Bio, Inc. | KRRO | Healthcare | 1.63% | 1,137,149 | - | - | $12,872,527 |